Via Nicolas Hulscher, MPH:
We declare a MAJOR victory against the Academic Journal Cartel and their PubPeer Mob enforcement apparatus.
Using high-resolution RNA sequencing on blood samples, we discovered that COVID-19 “vaccines” SEVERELY disrupt expression of THOUSANDS of genes—triggering mitochondrial failure, immune reprogramming, and cancerous activity that can persist for MONTHS to YEARS post-injection.
🧬Differential gene expression analysis compared mRNA-injured patients (cancer, adverse events) to 803 healthy controls — revealing widespread transcriptomic CHAOS:
⚠️ Mitochondrial failure – Complex I breakdown, oxidative stress, energy collapse
⚠️ Immune reprogramming – Chronic inflammation, ACE2 suppression, TLR hyperactivation
⚠️ Oncogenic activation – MYC up, p53/KRAS down, DNA repair suppression
⚠️ Cellular stress – Ribosome overload, misfolded protein buildup, proteasome activation
⚠️ Epigenetic remodeling – Chromatin shifts, methylation changes, nucleosome displacement
⚠️ Reverse transcription suggested – Patterns consistent with LINE-1 activity and persistent plasmid DNA, raising concern for potential genomic integration or sustained foreign gene expression
Earlier this year, our study became one of the most-read and most-downloaded preprints in the world. Shortly thereafter, it was abruptly WIPED from the preprint sever AND ResearchGate.
We identified that this unethical removal was likely the result of coordinated Bio-Pharmaceutical Complex pressure and PubPeer Mob attacks, intended to shield the deadly mRNA platform.
Their efforts have failed miserably.
Now, two things need to happen:
- Immediate market withdrawal of the mRNA injections
- Formal RICO investigations into the Academic Journal Cartel and its PubPeer enforcement apparatus
Via: @neo7bioscience @Docjohnc @P_McCulloughMD @McCulloughFund @Kevin_McKernan @MediGenomics @NicHulscher
Thanks to the tireless work of Neo7Bioscience (Dr. John Catanzaro, Dr. Natalia von Ranke, Dr. Wei Zhang, Dr. Philipp Anokin), the McCullough Foundation (Dr. Peter McCullough and Nicolas Hulscher) and Medicinal Genomics (Kevin McKernan) for getting this through the finish line.